1EUROASPIRE II Study Group. Lifestyle and risk factormanagement and use of drug therapies in coronary patients from15 countries ; principal results from EUROASPIRE U EuroHeart Survey Programme [ J ]. Eur Heart J, 2001, 22 (7):554-572.
2YANG W, XIAO J, YANG Z, et al. Serum lipids andlipoproteins in Chinese men and women [ J ]. Circulation, 2012,125(18): 2212-2221.
3JONES P, KAFONEK S,LAURORA I,et al. Comparativedose efficacy study of atorvastatin versus simvastatin,pravastatin, lovastatin, and fluvastatin in patients withhypercholesterolemia (the CURVES study) [J]. Am J Cardiol,1998, 81(5): 582-587.
4Sharp Collaborative Group. Study of Heart and Renal Protection(SHARP) : randomized trial to assess the effects of loweringlow-density lipoprotein cholesterol among 9,438 patients withchronic kidney disease[J]. Am Heart J, 2010, 160(5) : 785-794.el0.
5DAVIDSON M H, MCGARRY T, BETTIS R, et al. Ezetimibecoadministered with simvastatin in patients with primaryhypercholesterolemia [J]. J Am Coll Cardiol, 2002 , 40( 12):2125-2134.
6MELANI L, MILLS R, HASSMAN D,et al. Efficacy andsafety of ezetimibe coadministered with pravastatin in patientswith primary hypercholesterolemia : a prospective, randomized,double-blind trial [J]. Eur Heart J, 2003,24(8) : 717-728.
